Both in Pharmaceuticals
Ionis Pharmaceuticals vs Amneal Pharmaceuticals
Over the past year IONS returned −31.7% and AMRX returned +101.2%; their daily moves had a correlation of 0.17.
IONS −31.7% AMRX +101.2%Growth of $1, one year, split-adjusted
| Metric | IONS | AMRX |
|---|---|---|
| Price | $44.65 | $20.14 |
| Market cap | $7.42B | $7.01B |
| Today | −2.70% | −0.30% |
| 1 month | −26.0% | +15.3% |
| 6 months | −40.5% | +62.0% |
| Year to date | −43.6% | +59.8% |
| 1 year | −30.4% | +104.1% |
| Revenue growth (YoY) | −40.7% | +9.9% |
| Gross margin | 99.0% | 42.0% |
| Net margin | −42.8% | 7.2% |
| P/E (TTM) | — | 44.6× |
| Price / sales | 8.5× | 2.3× |
| Net cash | $732.0M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 40.0% |
| Short % of float | 12.8% | 6.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).